1. Romano F, Lamanna F, Gabrielle PH, et al. Update on retinal vein occlusion. Asia Pac J Ophthalmol (Phila.) 2023;12(2):196-210.
2. Becker B, Post LT, Jr. Retinal vein occlusion. Clinical and experimental observations. Am J Ophthalmol. 1951;34(5 1):677-686.
3. Song P, Xu Y, Zha M, Zhang Y, Rudan I. Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors. J Glob Health. 2019;9(1):010427.
4. Noma H, Yasuda K, Shimura M. Cytokines and pathogenesis of central retinal vein occlusion. J Clin Med. 2020;9(11):3457.
5. Jaulim A, Ahmed B, Khanam T, Chatziralli IP. Branch retinal vein occlusion: epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature. Retina. 2013; 33(5):901-910.
6. Janssen MC, den Heijer M, Cruysberg JR, Wollersheim H, Bredie SJ. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost. 2005;93(6):1021-1026.
7. O’Mahoney PR, Wong DT, Ray JG. Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol. 2008; 126(5):692-699.
8. Aggarwal RS, Mishra VV, Aggarwal SV. Oral contraceptive pills: a risk factor for retinal vascular occlusion in in-vitro fertilization patients. J Hum Reprod Sci. 2013;6(1):79-81.
9. Ashkenazy N, Patel NA, Sridhar J, et al. Hemi- and central retinal vein occlusion associated with COVID-19 infection in young patients without known risk factors. Ophthalmol Retina. 2022;6(6):520-530.
10. Yin X, Li J, Zhang B, Lu P. Association of glaucoma with risk of retinal vein occlusion: a meta-analysis. Acta Ophthalmol. 2019;97(7):652-659.
11. Coşkun M, Anayol MA, Toklu Y, Altıntaş AGK, Şimşek Ş. Retina ven dal tıkanıklığı olan olgularda aksiyel uzunluk, ön kamara derinliği ve optik disk çaplarının incelenmesi. J Retina Vitreous. 2008;16:2.
12. Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: the Beaver Dam eye study. Trans Am Ophthalmol Soc. 2000;98:133-143.
13. Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains eye study. Arch Ophthalmol. 1996;114(10):1243-1247.
14. Ip M, Hendrick A. Retinal vein occlusion review. Asia Pac J Ophthalmol (Phila). 2018;7(1):40-45.
15. Ghoghari H, Rizvi SF, Loya H, Razzak K. Axial length, a risk factor for retinal vein occlusion: a case control study. J Pak Med Assoc. 2019; 69(12):1800-1802.
16. Szigeti A, Schneider M, Ecsedy M, Nagy ZZ, Récsán Z. Association between retinal vein occlusion, axial length and vitreous chamber depth measured by optical low coherence reflectometry. BMC Ophthalmol. 2015;15:45.
17. Çiloğlu E, Köker ÖF, Özcan AA. Retina ven tıkanıklığında göz içi basınç ve aksiyel uzunluk değerlendirilmesi. J Glaucoma-Cataract. 2013;8:2.
18. Vural GS, Karahan E. Central corneal thickness, axial length, anterior chamber and optic disc structure in patients with central and branch retinal vein occlusion. Eur J Ophthalmol. 2022:11206721221131705.
19. Longo A, Avitabile T, Uva MG, et al. Optic nerve head in central retinal vein occlusion by spectral-domain OCT. Eur J Ophthalmol. 2017;27(4): 485-490.
20. Feist RM, Ticho BH, Shapiro MJ, Farber M. Branch retinal vein occlusion and quadratic variation in arteriovenous crossings. Am J Ophthalmol. 1992;113(6):664-668.
21. Wu SC, Lee YS, Wu WC, Chang SH. Anterior chamber depth and angle-closure glaucoma after central retinal vein occlusion. BMC Ophthalmol. 2016;16:68.